Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapSoil Technologies is an Israeli biotech and food-tech company specializing in a proprietary nanotechnological platform that converts lipophilic (oil-based) substances into stable, water-soluble powders. This technology enables the seamless integration of oils such as vitamins, antioxidants, and cannabinoids into various delivery formats, including beverages, tablets, and topical applications, without altering their chemical profile. By enhancing the bioavailability and stability of these active ingredients, CapSoil addresses significant challenges in the nutraceutical, pharmaceutical, and cosmetic industries. The company's process is cold-pressed and does not involve chemicals or surfactants, maintaining the integrity of the original oil. CapSoil's platform is designed to be highly scalable, allowing for the mass production of functional ingredients that were previously difficult to formulate in aqueous environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapSoil Technologies.